Results 121 to 130 of about 12,412 (210)

Fractional Carbon Dioxide Laser Combined with Secukinumab in the Treatment of Refractory Psoriasis Lesions on the Lower Legs [PDF]

Hui Ye,1,2,* Wei Li,1– 3,* Yichuan Gan,1,2 Enyi Zhu,1,2 Hongkai Zheng,1,2 Quan Luo,1,2 Sanquan Zhang,1,2 Xibao Zhang1,2 1Institute of Dermatology, Guangzhou Medical University, Guangzhou, 510095, People’s Republic of China; 2Department of ...
Li W, Luo Q, Zheng H, Zhang X, Zhu E, Gan Y, Zhang S, Ye H   +7 more
core  

Interplay between COVID-19 and Secukinumab treatment in Spondylarthritis patients during the omicron surge: a retrospective cohort study

Autoimmunity
The objective of this retrospective cohort study was to assess the relationship between Corona Disease 2019 (COVID-19) and Secukinumab treatment in patients with Spondylarthritis (SpA) in China during the omicron surge. Researchers retrieved 1018 medical
Tong Wu, Yanhong Li, Deying Huang, Yinlan Wu, Xiuping Liang, Lu Cheng, Zehui Liao, Fang Xu, Ye Chen, Jing Zhao, Zijing Xia, Chunyu Tan, Yi Liu, Martin Herrmann   +13 more
doaj   +1 more source

Treatment‐associated phenotype switching between psoriasis and atopic dermatitis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This international, multicentre real‐world study of 148 patients’ documents treatment‐associated, bidirectional phenotype switching between psoriasis and atopic dermatitis. Psoriasis‐to‐eczematous switches occurred predominantly with IL‐17 and IL‐23 inhibitors, whereas AD‐to‐psoriasiform switches occurred exclusively during treatment with biologic ...
Tiago Torres, Mario Valenti, Anna Balato, Matteo Megna, Paolo Gisondi, Vimal Prajapati, Stefano Piaserico, Julia‐Tatjana Maul, Lara Valeska Maul, Jose Manuel Carrascosa, Francisco José Navarro‐Triviño, Elizabeth Lazaridou, César Ferreira, Jacopo Tartaglia, Christian Ciolfi, Athina‐Ioanna Daponte, Eugenia Veronica Di Brizzi, Maddalena Napolitano, Barbara Leal Guerra, Monica Munera‐Campos, Siddhartha Sood, Silvia Ferruci, Francesca Prignano, Esteban Dauden, Mar Llamas‐Velasco, Ron Vender, Jensen Yeung, Angelo Marzano, Luis Puig   +28 more
wiley   +1 more source

Successful secukinumab treatment of generalized pustular psoriasis [PDF]

Generalized pustular psoriasis is a rare variant of psoriasis. Evidence recommending generalized pustular psoriasis treatment with secukinumab is limited.
Ma, Li-Li, Hu, Ting, Zhou, Xiu-Lian, Liu, Fang-Yan, Guo, Heng-Shan, Li, Wei-Quan, Liu, Min-Hong, Chen, Hong-Hui   +7 more
core   +1 more source

Measuring success in HS treatment from the physician's and the patient's perspective

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Integrated clinician (HiSCR, IHS4, IHS4‐55, HS‐IGA) and patient (HiSQOL, DLQI) scores, combined with imaging‐based fibrosis and inflammation assessment, redefine treatment success in hidradenitis suppurativa by aligning treat‐to‐target strategies with both inflammatory control and irreversible structural damage.
Georgios Nikolakis, Monika Arenbergerova, Zeljko Mijuskovic, Baoxi Wang, Christos C. Zouboulis   +4 more
wiley   +1 more source

Secukinumab induced Behcet's syndrome: a report of two cases

, 2019
Secukinumab is a human monoclonal antibody against IL-17A that has been shown to be effective in psoriasis, psoriatic arthritis and ankylosing spondylitis (AS).
MELİKOĞLU, Melike, Yurttas, Berna, HAMURYUDAN, Vedat, Esatoglu, Sinem N., SEYAHİ, Emire, Dincses, Elif   +5 more
core   +1 more source

Periodontitis and rheumatoid arthritis—Global efforts to untangle two complex diseases

Periodontology 2000, EarlyView.
Abstract Understanding the impact of oral health on rheumatoid arthritis (RA) will inform how best to manage patients with both periodontitis and RA. This review seeks to provide an update on interventional and mechanistic investigations, including a brief summary of European Research programs investigating the link between periodontitis and RA. Recent
Isabel Lopez‐Oliva, Jennifer Malcolm, Shauna Culshaw   +2 more
wiley   +1 more source

Secukinumab in the treatment of psoriasis: an update

, 2017
Biological drugs are pharmaceuticals manufactured using biotechnology methods that may target specific cytokines, cytokine receptors or surface molecules, and modulate the immunological response of the organism.
Jacek C Szepietowski, Radomir Reszke
core   +1 more source

Sarcoidosis Developing During Secukinumab Therapy: Case Report

, 2017
Introduction: Sarcoidosis is a systemic granulomatous inflammatory disease with an unknown etiology and complex pathogenesis. Existing literature supports the relationship of new-onset sarcoidosis with the use of a several biologic agents. Since the skin
Roger Ceilley, Timothy Nyckowski, Joshua Wilson   +2 more
core   +1 more source

Clinical characteristics and outcomes of paradoxical palmoplantar pustulosis during secukinumab therapy in biologic-naïve patients with plaque psoriasis: a retrospective case series

Journal of Dermatological Treatment
Background Palmoplantar pustulosis (PPP) is an uncommon paradoxical reaction associated with biologic therapy. However, secukinumab-induced PPP remains poorly characterized, particularly in biologic-naïve patients with plaque psoriasis.Objective To ...
Qigong Si, Yi Zhang, Jing Li, Na Zhu, Ziqi Li, Hongxia Yan, Rina Wu, Xigetu He, Li Liu, Qiri Mu   +9 more
doaj   +1 more source